Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
basic toxicokinetics in vivo
Adequacy of study:
disregarded due to major methodological deficiencies
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
other: Original reference not available.

Data source

Reference
Reference Type:
other: Patient information sheet
Title:
Actifed.
Author:
Warner Lambert
Year:
1986
Bibliographic source:
Toxicological properties reported on an information sheet for medical and pharmaceutical personnel.

Materials and methods

Objective of study:
toxicokinetics

Results and discussion

Toxicokinetic / pharmacokinetic studies

Details on absorption:
Pseudoephedrine was resorbed quickly and completely from the gastrointestinal tract. Plasma peaks have been measured after 2 hours. Plasma half-life time was 5.5 hours if the urine pH was between 5.0 and 7.0. After acidification of urine the excretion will be accelerated whereas alkalisation leeds to a decelerated excretion.
Details on excretion:
Plasma half-life time was 5.5 hours if the urine pH was between 5.0 and 7.0. After acidification of urine the excretion will be accelerated whereas alkalisation leeds to a decelerated excretion.

Metabolite characterisation studies

Metabolites identified:
yes
Details on metabolites:
Pseudoephedrine is partly metabolised in the liver, where N-demethylation may occur. The resulting metabolite has shown to be still active. Excretion of pseudoephedrine and the metabolite occurs by renal excretion, with 55-75% of the dose beeing excreted unchanged.

Applicant's summary and conclusion